Azinone-substituted azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine MCH-1 antagonists, methods of making, and use thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9073925
APP PUB NO 20110003739A1
SERIAL NO

12828955

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Novel MCH-1 receptor antagonists are disclosed. These compounds are used in the treatment of various disorders, including obesity, anxiety, depression, non-alcoholic fatty liver disease, and psychiatric disorders. Methods of making these compounds are also described in the present invention.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
APOLLO ADMINISTRATIVE AGENCY LLC AS SUCCESSOR AGENT9 WEST 57TH STREET NEW YORK NY 10019

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Guzzo, Peter R Niskayuna, US 38 316
Surman, Matthew David Albany, US 17 154
Zhu, Lei Schenectady, US 374 2364

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 7, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00